What are appropriate controls for cardiac interleukin-6 expression in heart failure?

Circulation. 2003 Oct 28;108(17):e129-30; author reply e129-30. doi: 10.1161/01.CIR.0000096409.32921.B8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antigens, CD / metabolism
  • Cardiomyopathy, Dilated / metabolism*
  • Cytokine Receptor gp130
  • Cytokines / biosynthesis
  • DNA-Binding Proteins / metabolism
  • Heart Failure / metabolism*
  • Heart Ventricles / metabolism
  • Humans
  • Interleukin-6 / biosynthesis*
  • Janus Kinase 2
  • Membrane Glycoproteins / metabolism
  • Myocardium / metabolism
  • Phosphorylation
  • Protein-Tyrosine Kinases / metabolism
  • Proteins / metabolism
  • Proto-Oncogene Proteins*
  • RNA, Messenger / metabolism
  • Receptors, Cytokine / biosynthesis
  • Receptors, Interleukin-6 / genetics
  • Receptors, Interleukin-6 / metabolism
  • STAT3 Transcription Factor
  • Signal Transduction
  • TYK2 Kinase
  • Trans-Activators / metabolism

Substances

  • Antigens, CD
  • Cytokines
  • DNA-Binding Proteins
  • IL6ST protein, human
  • Interleukin-6
  • Membrane Glycoproteins
  • Proteins
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Receptors, Cytokine
  • Receptors, Interleukin-6
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Trans-Activators
  • Cytokine Receptor gp130
  • Protein-Tyrosine Kinases
  • JAK2 protein, human
  • Janus Kinase 2
  • TYK2 Kinase
  • TYK2 protein, human